Place conditioning in humans: opportunities for translational research.

Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2072 (Electronic) Linking ISSN: 00333158 NLM ISO Abbreviation: Psychopharmacology (Berl) Subsets: MEDLINE

Original Publication: Berlin, New York, Springer-Verlag.

Translational Research, Biomedical* ; Behavior, Addictive*; Animals ; Humans ; Emotions ; Reward

Rationale: Translational research, especially research that bridges studies with humans and nonhuman species, is critical to advancing our understanding of human disorders such as addiction. This advancement requires reliable and rigorous models to study the underlying constructs contributing to the maladaptive behavior.
Objective: In this commentary, we address some of the challenges of conducting translational research by examining a single procedure, place conditioning. Place conditioning is commonly used with laboratory animals to study the conditioned rewarding effects of drugs, and recent studies indicate that a similar procedure can be used in humans.
Results: We discuss the opportunities and challenges of making the procedure comparable across species, as well as discuss the benefits of more systematically applying the procedure to humans.
Conclusion: We argue that the capacity of humans to report verbally on their internal experiences (perceptions, affective states, likes and dislikes) add an important dimension to the understanding of the procedures used in laboratory animals.
(© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)

Behav Brain Res. 2015 Sep 15;291:277-282. (PMID: 26003943)
Support Care Cancer. 2005 Feb;13(2):117-21. (PMID: 15599779)
Neuropsychopharmacology. 2013 May;38(6):921-9. (PMID: 23416857)
J Pharmacol Exp Ther. 1991 Dec;259(3):1165-73. (PMID: 1762068)
Alcohol. 2017 Feb;58:19-22. (PMID: 28109344)
Drug Alcohol Depend. 2008 Aug 1;96(3):202-12. (PMID: 18430522)
Neurobiol Learn Mem. 2020 Jul;172:107235. (PMID: 32389881)
Neurosci Biobehav Rev. 2005;29(4-5):707-14. (PMID: 15876456)
Drug Alcohol Depend. 2019 Aug 1;201:236-243. (PMID: 31254750)
Am J Psychiatry. 2021 Jun;178(6):560-571. (PMID: 33397141)
Behav Brain Res. 2007 Jul 19;181(1):35-41. (PMID: 17451818)
Pol J Pharmacol. 1995 Mar-Apr;47(2):189-91. (PMID: 8688894)
Prog Neurobiol. 1998 Dec;56(6):613-72. (PMID: 9871940)
Psychopharmacology (Berl). 1982;77(4):379-82. (PMID: 6813901)
Behav Brain Res. 2020 Jan 27;378:112299. (PMID: 31634497)
Behav Neurosci. 2008 Feb;122(1):140-50. (PMID: 18298257)
Front Psychol. 2016 Aug 09;7:1175. (PMID: 27555829)
ACS Chem Neurosci. 2010 Mar 10;1(4):265-278. (PMID: 20495676)
Synapse. 2005 Apr;56(1):57-9. (PMID: 15700283)
Biol Psychiatry. 2009 May 15;65(10):900-4. (PMID: 19111278)
Pharmacol Biochem Behav. 1986 Nov;25(5):1101-5. (PMID: 3786364)
Behav Brain Res. 2008 Mar 5;187(2):433-41. (PMID: 18055028)
Neurosci Biobehav Rev. 2013 Nov;37(9 Pt A):2081-6. (PMID: 23680702)
Genes Brain Behav. 2020 Mar;19(3):e12601. (PMID: 31364813)
Addiction. 2016 Dec;111(12):2157-2165. (PMID: 27447940)
Cold Spring Harb Perspect Med. 2013 Apr 01;3(4):a011932. (PMID: 23249442)
Pharmacol Biochem Behav. 1999 May;63(1):131-6. (PMID: 10340533)
Neuroimage. 2010 Feb 15;49(4):3373-84. (PMID: 19948225)
Int J Neuropsychopharmacol. 2010 Mar;13(2):171-80. (PMID: 19775503)
Psychopharmacology (Berl). 2000 Dec;153(1):31-43. (PMID: 11255927)
Behav Pharmacol. 2013 Jun;24(3):207-13. (PMID: 23591124)
Psychopharmacology (Berl). 2016 Jun;233(11):2015-2024. (PMID: 25066361)
Comp Med. 2010 Jun;60(3):177-88. (PMID: 20579432)
Behav Brain Res. 2017 Mar 30;322(Pt A):110-114. (PMID: 28108321)
J Neurosci Methods. 2020 Sep 1;343:108857. (PMID: 32652184)
Behav Brain Res. 2016 Jan 15;297:15-9. (PMID: 26439185)
Neurosci Biobehav Rev. 1995 Spring;19(1):39-51. (PMID: 7770196)
Nat Protoc. 2006;1(4):1662-70. (PMID: 17487149)
Cannabis Cannabinoid Res. 2016 Apr 01;1(1):113-121. (PMID: 28861486)
Nat Rev Neurosci. 2020 Nov;21(11):625-643. (PMID: 33024318)
Br J Addict. 1991 Dec;86(12):1559-62. (PMID: 1786487)
Horm Behav. 2009 Jan;55(1):93-7. (PMID: 18835271)
Alcohol Clin Exp Res. 2020 Dec;44(12):2579-2587. (PMID: 33201577)
Nat Commun. 2022 Nov 4;13(1):6662. (PMID: 36333323)
J Neurosci Methods. 2003 Sep 30;128(1-2):103-10. (PMID: 12948553)
Pharmacol Biochem Behav. 2000 Dec;67(4):693-9. (PMID: 11166059)
Behav Neurosci. 2010 Feb;124(1):141-151. (PMID: 20141289)
Ann N Y Acad Sci. 2013 Apr;1282:1-11. (PMID: 23496247)
Brain Res. 2008 Jun 5;1213:57-68. (PMID: 18455710)
J Stud Alcohol Drugs. 2016 Mar;77(2):317-26. (PMID: 26997190)
Behav Processes. 2013 Jan;92:31-5. (PMID: 23089383)
Front Behav Neurosci. 2020 Sep 29;14:582147. (PMID: 33132862)
Alcohol Clin Exp Res. 1987 Feb;11(1):52-9. (PMID: 3551664)
Addict Behav. 2018 Feb;77:51-58. (PMID: 28957728)
Addict Biol. 2013 Nov;18(6):985-92. (PMID: 22129527)
Pharmacol Biochem Behav. 1999 Nov;64(3):507-12. (PMID: 10548263)
Clin Pharmacol Ther. 1979 May;25(5 Pt 1):611-7. (PMID: 108042)
Nat Neurosci. 2009 Nov;12(11):1364-6. (PMID: 19783992)
Appetite. 2013 Nov;70:73-80. (PMID: 23831016)
Methods Mol Biol. 2021;2201:221-229. (PMID: 32975803)
Curr Top Behav Neurosci. 2013;13:611-45. (PMID: 21671191)
Ann Neurosci. 2010 Jul;17(3):136-41. (PMID: 25205891)
Behav Processes. 2021 Jun;187:104340. (PMID: 33545315)
Nat Rev Neurosci. 2022 Jun;23(6):361-375. (PMID: 35444305)
Behav Brain Res. 2022 May 24;426:113834. (PMID: 35304186)
Pharmacol Biochem Behav. 2008 Jan;88(3):256-64. (PMID: 17888504)
Pharmacol Biochem Behav. 1994 Jul;48(3):581-6. (PMID: 7938109)
Behav Brain Res. 2014 Jul 1;267:173-7. (PMID: 24657735)
Pharmacol Biochem Behav. 1992 Sep;43(1):235-41. (PMID: 1409809)
Behav Neurosci. 2001 Jun;115(3):683-94. (PMID: 11439457)
Addict Biol. 2007 Sep;12(3-4):227-462. (PMID: 17678505)

T32 DA043469 United States DA NIDA NIH HHS; T32DA043469 United States DA NIDA NIH HHS; P20 GM130461 United States GM NIGMS NIH HHS; R01 DA002812 United States DA NIDA NIH HHS; R01 DA046109 United States DA NIDA NIH HHS

Keywords: Conditioned drug effects; Pavlovian place conditioning; Substance abuse; Translational research

Date Created: 20230119 Date Completed: 20240321 Latest Revision: 20240321

20240321

PMC10949408

10.1007/s00213-023-06316-8

36656336